tiprankstipranks
Evgen Pharma PLC (GB:TCF)
LSE:TCF
UK Market

Evgen Pharma (TCF) Income Statement

Compare
1 Followers

Evgen Pharma Income Statement

Last quarter (Q4 2023), Evgen Pharma's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q4, Evgen Pharma's net income was £-1.68M. See Evgen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
£ 396.00K£ 442.00K£ 0.00£ 194.00K£ 0.00
Gross Profit
£ 385.00K£ 429.00K£ -16.00K£ 194.00K£ -21.00K
Operating Expenses
£ 3.94M£ 5.50M£ 3.17M£ 3.38M£ 3.13M
Depreciation and Amortization
£ 11.00K£ 13.00K£ 16.00K£ 18.00K£ 21.00K
EBITDA
£ -3.55M£ -4.99M£ -3.15M£ -3.19M£ -3.15M
Operating Income
£ -3.56M£ -5.07M£ -3.19M£ -3.20M£ -3.15M
Other Income/Expenses
£ -6.00K£ 64.00K£ 22.00K£ -9.00K£ -20.00K
Pretax Income
£ -3.57M£ -5.01M£ -3.17M£ -3.21M£ -3.17M
Net Income
£ -3.14M£ -4.04M£ -2.73M£ -2.67M£ -2.71M
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.01£ -0.01£ -0.01£ -0.02£ -0.02
Diluted EPS
£ -0.01£ -0.01£ -0.01£ -0.02£ -0.02
Weighted Average Shares Outstanding
274.89M 274.89M 274.89M 147.02M 131.23M
Weighted Average Shares Outstanding (Diluted)
274.89M 274.89M 274.89M 147.02M 131.23M
Currency in GBP

Evgen Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis